Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05154929 · ClinicalTrials.gov registry record · NA
Improving Blood Pressure Control Through the myBPmyLife mHealth Application
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 608
- Enrollment target
NCT05154929: Completed NA study, sponsored by University of Michigan.
NCT05154929 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 608 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05154929, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 608 participants
- Enrollment target
Study Summary
This study is enrolling eligible participants that have high blood pressure. Reducing dietary salt intake and engaging in regular physical activity is known to decrease blood pressure in people with hypertension. This trial will determine whether a smartwatch and a mobile health application, which together deliver notifications, can increase activity levels and reduce salt intake for people with high blood pressure. All study activities will be completed online or via a mobile medical application. Participants will not have any face-to-face visits with the study team.
Interventions
- OTHER Control Group
- BEHAVIORAL Dietary and physical activity JITAI delivered through the myBPmyLife app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 608 participants |
| Start Date | 2021-12-21 |
| Est. Completion | 2024-01-27 |
| Phase | NA |
What the finished NCT05154929 record still lists
NCT05154929 is an interventional study that assigns participants to a tested intervention. The registered 608 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 2 interventions - of which Control Group is the first listed.
NCT05154929 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05154929 about?
NCT05154929 is a clinical study titled "Improving Blood Pressure Control Through the myBPmyLife mHealth Application". This study is enrolling eligible participants that have high blood pressure. Reducing dietary salt intake and engaging in regular physical activity is known to decrease blood pressure in people with hypertension. This trial will determine whether a smartwatch and a mobile health application, which t...
What is the current status of trial NCT05154929?
This trial is currently completed. It is a NA study. The enrollment target is 608 participants. The study started on 2021-12-21. Estimated completion is 2024-01-27.
What interventions are being tested in trial NCT05154929?
The interventions under investigation include: Control Group (OTHER), Dietary and physical activity JITAI delivered through the myBPmyLife app (BEHAVIORAL).
Who is sponsoring clinical trial NCT05154929?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05154929's enrollment target sits among peer trials
608 162nd of 2000 higher than 1,839 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02064673 · 608 participants · Phase 3
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
- NCT06091202 · 608 participants · Phase 3
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
- NCT06098144 · 608 participants · Phase 4
Smoking Cessation Program in the Construction Sector
- NCT00823654 · 609 participants
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI